VIVA BIOTECH (01873.HK) spent 0.919 million HKD to repurchase 1.05 million shares on December 16.

Gelonghui, December 16 - VIVA BIOTECH (01873.HK) announced that on December 16, it spent 0.919 million Hong Kong dollars to repurchase 1.05 million shares.

Gelonghui FinanceDec 16 18:05

December 13 repurchase collection | TENCENT, AIA and others have repurchased shares, among which TENCENT spent 0.703 billion Hong Kong dollars.

According to the documents disclosed by the HKEX on December 16, TENCENT (00700.HK), AIA (01299.HK), and others have repurchased shares. ① TENCENT (00700.HK) repurchased 1.71 million ordinary shares on December 13, involving an amount of 0.703 billion HKD, with the repurchase price ranging from 414.6 HKD to 408.6 HKD per share. Since the repurchase authorization resolution, the total number of securities repurchased is 0.214 billion shares, accounting for 2.274% of the number of shares issued at the time the ordinary resolution was passed. ② AIA (01299.HK)

Futu NewsDec 16 09:30

VIVA BIOTECH (01873.HK) spent 0.448 million HKD to repurchase 0.5 million shares on December 13.

Gelonghui, December 13丨VIVA BIOTECH (01873.HK) announced that on December 13, HKD 0.448 million was spent to repurchase 0.5 million shares.

Gelonghui FinanceDec 13 18:22

Repurchase Collection on December 11 | Tencent Holdings, AIA, etc. bought back one after another, of which Tencent Holdings spent HK$0.702 billion

According to documents disclosed by the Hong Kong Stock Exchange on December 12, $Tencent Holdings (00700.HK) $ and $AIA (01299.HK) $ repurchased shares. ① $Tencent Holdings (00700.HK) $ repurchased 1.71 million common shares on December 11, involving an amount of HK$0.702 billion. The repurchase price per share ranged from HK$414.8 to HK$407.2. Since the repurchase authorization resolution, the cumulative number of repurchased securities was 0.211 billion shares, accounting for 2.238% of the number of shares issued when the ordinary resolution was passed. ② $AIA (01299.HK) $

Futu NewsDec 12 09:20

Express News | CITIC Construction Investment: Optimistic about investment opportunities in the pharmaceutical industry in 2025, focusing on new volume and industry integration opportunities

BreakingsDec 12 07:38

VIVA BIOTECH (01873.HK) spent 0.093 million Hong Kong dollars to repurchase 0.1 million shares on December 11.

Gelonghui, December 11th丨VIVA BIOTECH (01873.HK) announced that on December 11th, it spent 0.093 million Hong Kong dollars to repurchase 0.1 million shares.

Gelonghui FinanceDec 11 18:09